X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
BVF PARTNERS L P/IL's stake in X4 Pharmaceuticals, Inc. fell to 3.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
BVF PARTNERS L P/IL's stake in X4 Pharmaceuticals, Inc. fell to 3.90%, 3,411,993 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 3.90%
- Shares
- 3,411,993
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.10% | 1,827,005 |
| BVF I GP LLC | 2.10% | 1,827,005 |
| BIOTECHNOLOGY VALUE FUND II LP | 1.50% | 1,339,509 |
| BVF II GP LLC | 1.50% | 1,339,509 |
| Biotechnology Value Trading Fund OS LP | 0.20% | 194,535 |
| BVF Partners OS Ltd. | 0.20% | 194,535 |
| BVF GP HOLDINGS LLC | 3.60% | 3,166,514 |
| BVF PARTNERS L P/IL | 3.90% | 3,411,993 |
| BVF INC/IL | 3.90% | 3,411,993 |
| LAMPERT MARK N | 3.90% | 3,411,993 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Bvf Partners L P
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G · Bvf Partners L P · Aug 20, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026